{"transactions":[{"id":1281883,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-02-06T01:31:31.000Z","date":"2025-02-05","kind":"sale","planned":false,"acquired":false,"shares":106408,"price":0.78,"value":82998.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a \"sell to cover\" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on February 1, 2024."}],"balance_after":1736883,"source":{"system":"sec-edgar","filing":"0000950170-25-014850","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017025014850/ownership.xml","form_type":"4"}},{"id":1281882,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-02-06T01:31:31.000Z","date":"2025-02-05","kind":"sale","planned":false,"acquired":false,"shares":42786,"price":0.78,"value":33373.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a \"sell to cover\" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on February 1, 2023."}],"balance_after":1843291,"source":{"system":"sec-edgar","filing":"0000950170-25-014850","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017025014850/ownership.xml","form_type":"4"}},{"id":1281881,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-02-06T01:31:31.000Z","date":"2025-02-05","kind":"sale","planned":false,"acquired":false,"shares":6139,"price":0.78,"value":4788.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a \"sell to cover\" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on February 1, 2022."}],"balance_after":1886077,"source":{"system":"sec-edgar","filing":"0000950170-25-014850","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017025014850/ownership.xml","form_type":"4"}},{"id":1281880,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-02-06T01:31:31.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":751407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on February 3, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":1892216,"source":{"system":"sec-edgar","filing":"0000950170-25-014850","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017025014850/ownership.xml","form_type":"4"}},{"id":1419947,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-08-29T22:36:07.000Z","date":"2024-08-27","kind":"sale","planned":false,"acquired":false,"shares":2757,"price":1.35,"value":3721.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a \"sell to cover\" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on August 26, 2021."}],"balance_after":1140809,"source":{"system":"sec-edgar","filing":"0000950170-24-101993","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017024101993/ownership.xml","form_type":"4"}},{"id":1439653,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-08-06T23:56:12.000Z","date":"2024-08-05","kind":"sale","planned":false,"acquired":false,"shares":17641,"price":1.31,"value":23109.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of RSUs that were granted to the Reporting Person on August 1, 2023 pursuant to a \"sell to cover\" provision included in each RSU Agreement."}],"balance_after":1143566,"source":{"system":"sec-edgar","filing":"0000950170-24-092170","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017024092170/ownership.xml","form_type":"4"}},{"id":1439652,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-08-06T23:56:12.000Z","date":"2024-08-02","kind":"sale","planned":false,"acquired":false,"shares":14800,"price":1.32,"value":19536.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of RSUs that were granted to the Reporting Person on August 1, 2023 pursuant to a \"sell to cover\" provision included in each RSU Agreement."}],"balance_after":1161207,"source":{"system":"sec-edgar","filing":"0000950170-24-092170","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017024092170/ownership.xml","form_type":"4"}},{"id":1658953,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-02-06T01:40:36.000Z","date":"2024-02-05","kind":"sale","planned":true,"acquired":false,"shares":45093,"price":1.45,"value":65384.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The reported transaction is a sale of common stock pursuant to a preexisting 10b5-1 plan upon the vesting of RSUs that were granted to the Reporting Person on February 1, 2022 and February 1, 2023."}],"balance_after":1176007,"source":{"system":"sec-edgar","filing":"0000950170-24-011487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017024011487/ownership.xml","form_type":"4"}},{"id":1658952,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-02-06T01:40:36.000Z","date":"2024-02-02","kind":"sale","planned":true,"acquired":false,"shares":30901,"price":1.37,"value":42334.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of RSUs that were granted to the Reporting Person on February 1, 2022 and February 1, 2023 pursuant to a \"sell to cover\" provision included in each RSU Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $1.36 to $1.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":1221100,"source":{"system":"sec-edgar","filing":"0000950170-24-011487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017024011487/ownership.xml","form_type":"4"}},{"id":1658951,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-02-06T01:40:36.000Z","date":"2024-02-01","kind":"grant","planned":true,"acquired":true,"shares":679501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on February 1, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":1252001,"source":{"system":"sec-edgar","filing":"0000950170-24-011487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017024011487/ownership.xml","form_type":"4"}},{"id":1793061,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-08-30T20:20:21.000Z","date":"2023-08-29","kind":"sale","planned":true,"acquired":false,"shares":4163,"price":1.3,"value":5411.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transaction is a sale of common stock pursuant to a preexisting 10b5-1 plan upon the vesting of RSUs that were granted to the Reporting Person on August 26, 2021."}],"balance_after":572500,"source":{"system":"sec-edgar","filing":"0000950170-23-045441","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017023045441/ownership.xml","form_type":"4"}},{"id":1793060,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-08-30T20:20:21.000Z","date":"2023-08-28","kind":"sale","planned":true,"acquired":false,"shares":1854,"price":1.26,"value":2336.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\") that were granted to the Reporting Person on August 26, 2021 pursuant to a \"sell to cover\" provision included in the RSU Agreement."}],"balance_after":576663,"source":{"system":"sec-edgar","filing":"0000950170-23-045441","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017023045441/ownership.xml","form_type":"4"}},{"id":1816449,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-08-03T20:10:53.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":266000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on August 1, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":578517,"source":{"system":"sec-edgar","filing":"0000950170-23-037973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017023037973/ownership.xml","form_type":"4"}},{"id":2033063,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-04T00:41:41.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":9504,"price":1.8279,"value":17372.3616,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction is a sale of common stock pursuant to a preexisting 10b5-1 plan upon the vesting of RSUs that were granted to the Reporting Person on February 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $1.81 to $1.86 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 312,518 RSUs held by the Reporting Person."}],"balance_after":312517,"source":{"system":"sec-edgar","filing":"0000899243-23-003945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924323003945/doc4.xml","form_type":"4"}},{"id":2033062,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-04T00:41:41.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":265957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on February 1, 2024, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 312,518 RSUs held by the Reporting Person."}],"balance_after":322021,"source":{"system":"sec-edgar","filing":"0000899243-23-003945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924323003945/doc4.xml","form_type":"4"}},{"id":2170776,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-30T21:00:13.000Z","date":"2022-08-29","kind":"sale","acquired":false,"shares":6017,"price":0.8938,"value":5377.9946,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction is a sale of common stock pursuant to a preexisting 10b5-1 plan upon the vesting on August 26, 2022 of a portion of restricted stock units (\"RSUs\") granted to the Reporting Person on August 26, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $0.8839 to $0.9002 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of RSUs. Each RSU represents the right to receive one share of common stock upon vesting. 18,050 of the RSUs vest in three equal annual installments beginning on August 26, 2023 and 38,014 of the RSUs vest in four equal annual installments beginning on February 1, 2023, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":56064,"source":{"system":"sec-edgar","filing":"0000899243-22-030087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924322030087/doc4.xml","form_type":"4"}},{"id":2414053,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T21:19:40.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":53190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest as to 25% on February 1, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":53190,"derivative":{"exercise_price":11.18,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":53190},"source":{"system":"sec-edgar","filing":"0000899243-22-004593","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924322004593/doc4.xml","form_type":"4"}},{"id":2414052,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-03T21:19:40.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":38014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on February 1, 2023, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 62,081 RSUs held by the Reporting Person."}],"balance_after":62081,"source":{"system":"sec-edgar","filing":"0000899243-22-004593","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924322004593/doc4.xml","form_type":"4"}},{"id":2586623,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-30T20:15:13.000Z","date":"2021-08-26","kind":"grant","acquired":true,"shares":24067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on August 26, 2022, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":24067,"source":{"system":"sec-edgar","filing":"0000899243-21-034498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924321034498/doc4.xml","form_type":"4"}},{"id":2920820,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-05T21:20:08.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% on January 4, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting dates."}],"balance_after":75000,"derivative":{"exercise_price":17.93,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-21-000366","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924321000366/doc4.xml","form_type":"4"}},{"id":3296873,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-31T21:52:33.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":123900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2019."}],"balance_after":123900,"derivative":{"exercise_price":4.21,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":123900},"source":{"system":"sec-edgar","filing":"0001209191-20-005789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919120005789/doc4.xml","form_type":"4"}},{"id":3296872,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-31T21:52:33.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":80500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"26,834 shares shall vest on 12/31/2020 and 26,833 shares shall vest on each of 12/31/2021 and 12/31/2022."}],"balance_after":80500,"source":{"system":"sec-edgar","filing":"0001209191-20-005789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919120005789/doc4.xml","form_type":"4"}},{"id":3456890,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":83557,"kind":"person","name":"Shukla Sath","position":1,"cik":"0001782817","reported_name":"Shukla Sath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-07-24T12:57:03.000Z","date":"2019-07-22","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100,000 shares subject to the option shall vest on 7/22/2020; 25,000 shares subject to the option shall vest on a quarterly basis thereafter."}],"balance_after":400000,"derivative":{"exercise_price":5.6,"expiration_date":"2029-07-22","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-19-042993","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919119042993/doc4.xml","form_type":"4"}}]}